Suppr超能文献

超越肿瘤抑制:衰老与癌症干性和肿瘤休眠。

Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy.

机构信息

Biofarma Research Group, Center for Research in molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela, Avenida de Barcelona s/n, 15782 Santiago de Compostela, Spain.

出版信息

Cells. 2020 Feb 3;9(2):346. doi: 10.3390/cells9020346.

Abstract

Here, we provide an overview of the importance of cellular fate in cancer as a group of diseases of abnormal cell growth. Tumor development and progression is a highly dynamic process, with several phases of evolution. The existing evidence about the origin and consequences of cancer cell fate specification (e.g., proliferation, senescence, stemness, dormancy, quiescence, and cell cycle re-entry) in the context of tumor formation and metastasis is discussed. The interplay between these dynamic tumor cell phenotypes, the microenvironment, and the immune system is also reviewed in relation to cancer. We focus on the role of senescence during cancer progression, with a special emphasis on its relationship with stemness and dormancy. Selective interventions on senescence and dormancy cell fates, including the specific targeting of cancer cell populations to prevent detrimental effects in aging and disease, are also reviewed. A new conceptual framework about the impact of synthetic lethal strategies by using senogenics and then senolytics is given, with the promise of future directions on innovative anticancer therapies.

摘要

在这里,我们提供了一个关于细胞命运在癌症中的重要性的概述,癌症是一组异常细胞生长的疾病。肿瘤的发生和进展是一个高度动态的过程,经历了几个进化阶段。讨论了在肿瘤形成和转移的背景下,癌细胞命运特化(如增殖、衰老、干性、休眠、静止和细胞周期再进入)的起源和后果的现有证据。还讨论了这些动态肿瘤细胞表型、微环境和免疫系统之间的相互作用与癌症的关系。我们重点关注衰老在癌症进展中的作用,特别强调其与干性和休眠的关系。还回顾了对衰老和休眠细胞命运的选择性干预,包括针对特定的癌细胞群体以防止衰老和疾病中的有害影响。通过使用衰老诱导剂和衰老清除剂的合成致死策略,给出了一个新的概念框架,有望为创新的抗癌疗法提供未来的方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bad/7072600/9bb7b835e389/cells-09-00346-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验